对参加血糖测试筛查计划的参与者的特征进行系统回顾,脂质分布或它们的组合,分别。
流行病学检查表中观察性研究荟萃分析后的系统评价。
2000年1月1日至2020年4月1日的PubMed和Medline英语文献数据库。
本综述包括原始观察性研究,这些研究报告了明显健康的成人参与者筛查糖尿病和血脂紊乱的基线特征。
我们研究了他们的社会人口统计学特征,包括年龄,性别,体重指数(BMI)和生活习惯。通过横断面研究评估对纳入文章的质量进行评估。
本系统综述共纳入33篇文章,涉及22个国家的38项研究,并对其进行分析。总的来说,在所有筛查方式中,女性受试者的参与率均较高(女性vs男性:糖尿病筛查为46.6%-63.9%vs36.1%-53.4%;血脂筛查为48.8%-58.4%vs41.6%-51.2%;筛查为36.4%-76.8%vs23.2%-63.6%).与世界卫生组织的BMI标准相比,血脂筛查参与者的BMI较低(男性:23.8kg/m2vs24.2kg/m2,p<0.01;女性:22.3kg/m2vs23.6kg/m2,p<0.01).此外,在发达地区,社会经济地位较低的个体参与糖尿病或血脂筛查的可能性较小.
我们发现,在发达地区,来自较低社会经济群体的个体不太可能接受糖尿病和/或血脂筛查计划。这些人群也可能面临更高的非传染性疾病风险。未来的研究应该调查非参与者筛查的障碍和促进因素,有必要采取有针对性的干预措施来提高筛查率。
To perform a systematic
review on the characteristics of participants who attended screening programmes with blood glucose tests, lipid profiles or a combination of them, respectively.
Systematic
review following the Meta-analysis Of Observational Studies in Epidemiology checklist.
PubMed and Medline databases for English literature from 1 January 2000 to 1 April 2020.
Original observational studies that reported baseline characteristics of apparently healthy adult participants screening for diabetes and lipid disorders were included in this
review.
We examined their sociodemographic characteristics, including age, gender, body mass index (BMI) and lifestyle habits. The quality of the included articles was evaluated by the Appraisal of Cross-sectional Studies.
A total of 33 articles involving 38 studies in 22 countries were included and analysed in this systematic
review. Overall, there was a higher participation rate among subjects who were female in all screening modalities (female vs male: 46.6%-63.9% vs 36.1%-53.4% for diabetes screening; 48.8%-58.4% vs 41.6%-51.2% for lipid screening; and 36.4%-76.8% vs 23.2%-63.6% for screening offering both). Compared with the BMI standard from the WHO, participants in lipid screening had lower BMI (male: 23.8 kg/m2 vs 24.2 kg/m2, p<0.01; female: 22.3 kg/m2 vs 23.6 kg/m2, p<0.01). Furthermore, it is less likely for individuals of lower socioeconomic status to participate in diabetes or lipid screening in developed areas.
We identified that individuals from lower socioeconomic groups were less likely to take up programmes for diabetes and/or lipid screening in developed areas. These populations are also likely to be at higher risk of non-communicable diseases. Future studies should investigate the barriers and facilitators of screening among non-participants, where targeted interventions to enhance their screening uptake are warranted.